Literature DB >> 29945208

An Overview of Molecular Profiles in Ulcerative Colitis-Related Cancer.

Meng Xue1,2, Liuhong Shi3, Weijia Wang4, Shujie Chen5, Liangjing Wang1,2.   

Abstract

Ulcerative colitis (UC) is an independent risk factor of colorectal cancer (CRC). Both genetic and epigentic events induce a unique molecular profile during the development from UC to UC-related CRC (UCRC). These molecular changes play varied roles in DNA repair, immune response, cell metabolism, and interaction with the microbiota during the carcinogenesis process. This review will systmatically discuss the molecular characteristics of UCRC and point out the future perspectives in this research field.
© 2018 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  colorectal cancer; epigenetics; genetics; gut microbiota; molecule; ulcerative colitis

Mesh:

Year:  2018        PMID: 29945208     DOI: 10.1093/ibd/izy221

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  4 in total

1.  Transcription Factors That Regulate the Pathogenesis of Ulcerative Colitis.

Authors:  Bing Zhang; Tao Sun
Journal:  Biomed Res Int       Date:  2020-08-24       Impact factor: 3.411

2.  ELTD1 promotes invasion and metastasis by activating MMP2 in colorectal cancer.

Authors:  Jiawei Sun; Zizhen Zhang; Jingyu Chen; Meng Xue; Xia Pan
Journal:  Int J Biol Sci       Date:  2021-07-13       Impact factor: 6.580

3.  Retinoid acid induced 16 deficiency aggravates colitis and colitis-associated tumorigenesis in mice.

Authors:  Yu-Lin Xu; Cui-Ling Ding; Chun-Lin Qian; Zhong-Tian Qi; Wen Wang
Journal:  Cell Death Dis       Date:  2019-12-20       Impact factor: 8.469

4.  Artesunate alleviates the inflammatory response of ulcerative colitis by regulating the expression of miR-155.

Authors:  Zhao-Bin Yang; Lu-Zhen Qiu; Quan Chen; Jian-Dong Lin
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.